Registration Dossier

Identification

Chemical structure
Display Name:
Rifamycin, 4-O-(carboxymethyl)-1-deoxy-1,4-dihydro-4-hydroxy-1-oxo-, γ-lactone
EC Number:
238-493-1
EC Name:
Rifamycin, 4-O-(carboxymethyl)-1-deoxy-1,4-dihydro-4-hydroxy-1-oxo-, γ-lactone
CAS Number:
14487-05-9
Molecular formula:
C39H47NO14
IUPAC Name:
(7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-2,15,17-Trihydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-4',6,23,29-tetraoxospiro[8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(28), 2,4,9,19,21,25-heptaene-27,2'-[1,3]dioxolan]-13-yl acetate

Type of Substance

Composition:
mono-constituent substance
Origin:
organic

Substance Identifiers

Compositions

Boundary Composition(s) open all close all

State Form:
solid: particulate/powder


Constituent 1
Chemical structure
Reference substance name:
Rifamycin, 4-O-(carboxymethyl)-1-deoxy-1,4-dihydro-4-hydroxy-1-oxo-, γ-lactone
EC Number:
238-493-1
EC Name:
Rifamycin, 4-O-(carboxymethyl)-1-deoxy-1,4-dihydro-4-hydroxy-1-oxo-, γ-lactone
CAS Number:
14487-05-9
Molecular formula:
C39H47NO14
IUPAC Name:
(7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-2,15,17-Trihydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-4',6,23,29-tetraoxospiro[8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(28), 2,4,9,19,21,25-heptaene-27,2'-[1,3]dioxolan]-13-yl acetate

Legal Entity Composition(s) open all close all

State Form:
solid: particulate/powder


Constituent 1
Chemical structure
Reference substance name:
Rifamycin, 4-O-(carboxymethyl)-1-deoxy-1,4-dihydro-4-hydroxy-1-oxo-, γ-lactone
EC Number:
238-493-1
EC Name:
Rifamycin, 4-O-(carboxymethyl)-1-deoxy-1,4-dihydro-4-hydroxy-1-oxo-, γ-lactone
CAS Number:
14487-05-9
Molecular formula:
C39H47NO14
IUPAC Name:
(7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-2,15,17-Trihydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-4',6,23,29-tetraoxospiro[8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(28), 2,4,9,19,21,25-heptaene-27,2'-[1,3]dioxolan]-13-yl acetate


Constituent 1
Chemical structure
Reference substance name:
Rifamycin, 4-O-(carboxymethyl)-1-deoxy-1,4-dihydro-4-hydroxy-1-oxo-, γ-lactone
EC Number:
238-493-1
EC Name:
Rifamycin, 4-O-(carboxymethyl)-1-deoxy-1,4-dihydro-4-hydroxy-1-oxo-, γ-lactone
CAS Number:
14487-05-9
Molecular formula:
C39H47NO14
IUPAC Name:
(7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-2,15,17-Trihydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-4',6,23,29-tetraoxospiro[8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(28), 2,4,9,19,21,25-heptaene-27,2'-[1,3]dioxolan]-13-yl acetate
State Form:
solid: particulate/powder


Constituent 1
Chemical structure
Reference substance name:
Rifamycin, 4-O-(carboxymethyl)-1-deoxy-1,4-dihydro-4-hydroxy-1-oxo-, γ-lactone
EC Number:
238-493-1
EC Name:
Rifamycin, 4-O-(carboxymethyl)-1-deoxy-1,4-dihydro-4-hydroxy-1-oxo-, γ-lactone
CAS Number:
14487-05-9
Molecular formula:
C39H47NO14
IUPAC Name:
(7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-2,15,17-Trihydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-4',6,23,29-tetraoxospiro[8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(28), 2,4,9,19,21,25-heptaene-27,2'-[1,3]dioxolan]-13-yl acetate
State Form:
solid: particulate/powder


Constituent 1
Chemical structure
Reference substance name:
Rifamycin, 4-O-(carboxymethyl)-1-deoxy-1,4-dihydro-4-hydroxy-1-oxo-, γ-lactone
EC Number:
238-493-1
EC Name:
Rifamycin, 4-O-(carboxymethyl)-1-deoxy-1,4-dihydro-4-hydroxy-1-oxo-, γ-lactone
CAS Number:
14487-05-9
Molecular formula:
C39H47NO14
IUPAC Name:
(7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-2,15,17-Trihydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-4',6,23,29-tetraoxospiro[8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(28), 2,4,9,19,21,25-heptaene-27,2'-[1,3]dioxolan]-13-yl acetate

Composition(s) generated upon use

Other types of composition(s)